2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Faisal Khan

Session 7 – AI for Therapeutic Innovations
Date: 23 July (Thursday) 12:20 – 13:50 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform


Faisal Khan

Executive Director, Advanced Analytics and Artificial Intelligence
AstraZeneca


Faisal M. Khan, Ph.D. is the Executive Director of Advanced Analytics and Artificial Intelligence at Astrazeneca. His team focuses on the applications of AI and data science throughout the drug discovery lifecycle, from target identification through Phase 3 trials and beyond.  His interests focus on the intersections of data science, biostatistics, bioimaging, personalized medicine, and healthcare delivery. His career has encompassed all aspects of healthcare and biomedical analytics, including diagnostics, devices, clinical trials/therapeutics, and payers/insurance. Dr. Khan has worked or consulted across academia and industry with both startups and Fortune-50 companies. He has over 90 published papers, abstracts, and patent


Speech title & Synopsis

How to Apply AI to Different Stages of Drug Development